The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Open accessAbstract
BACKGROUND: There is growing awareness that tumour cells build up a "self-advantageous" microenvironment that reduces effectiveness of anti-tumour immune response. While many different immunosuppressive mechanisms are likely to come into play, recent evidence suggests that extracellular adenosine acting at A2A receptors may have a major role in down-modulating the immune response as cancerous tissues contain elevated levels of adenosine and adenosine break-down products. While there is no doubt that all cells possess plasma membrane adenosine transporters that mediate adenosine uptake and may also allow its release, it is now clear that most of extracellularly-generated adenosine originates from the catabolism of extracellular ATP. METHODOLOGY/PRINCIPAL FINDINGS: Measurement of extracellular ATP is generally performed in cell supernatants by HPLC or soluble luciferin-luciferase assay, thus it generally turns out to be laborious and inaccurate. We have engineered a chimeric plasma membrane-targeted luciferase that allows in vivo real-time imaging of extracellular ATP. With this novel probe we have measured the ATP concentration within the tumour microenvironment of several experimentally-induced tumours. CONCLUSIONS/SIGNIFICANCE: Our results show that ATP in the tumour interstitium is in the hundreds micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targeted luciferase allows in vivo detection of high extracellular ATP concentration at tumour sites. On the contrary, tumour-free tissues show undetectable extracellular ATP levels. Extracellular ATP may be crucial for the tumour not only as a stimulus for growth but also as a source of an immunosuppressive agent such as adenosine. Our approach offers a new tool for the investigation of the biochemical composition of tumour milieu and for development of novel therapies based on the modulation of extracellular purine-based signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, in a disease state as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors [68–70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2067 · Cited by 828
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 807
Adenosine, an endogenous distress signal, modulates tissue damage and repair
Fredholm, B. B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402132 · Cited by 704
Sitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697
ATP is a mediator of chemosensory transduction in the central nervous system
Gourine, A. V., Llaudet, E., Dale, N., & Spyer, K. M. (2005) · Nature · doi:10.1038/nature03690 · Cited by 537
Context, tissue plasticity, and cancer
Bissell, M. J., & LaBarge, M. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.013 · Cited by 517
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 670
Reporter cell lines for skin sensitization testing
Natsch, A., & Emter, R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1555-0 · Cited by 35
Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis
Martial, S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00218.2015 · Cited by 36
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Stokes, L., Bidula, S. M., Bibič, L., & Allum, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00627 · Cited by 37
Woods, L. T., Jasmer, K. J., Forti, K. M., Shanbhag, V., Camden, J. M., Erb, L., Petris, M. J., & Weisman, G. A. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104808 · Cited by 35
Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
Yan, D., Earp, H. S., DeRyckere, D., & Graham, D. K. (2021) · Cancers · doi:10.3390/cancers13225639 · Cited by 35
Potential role of P2X7R in esophageal squamous cell carcinoma proliferation
Santos, A. A., Cappellari, A. R., de Marchi, F. O., Gehring, M. P., Zaparte, A., Brandão, C. A., Lopes, T. G., da Silva, V. D., Pinto, L. F. R., Savio, L. E. B., et al. (2017) · Purinergic Signalling · doi:10.1007/s11302-017-9559-2 · Cited by 35
Hoki, T., Katsuta, E., Yan, L., Takabe, K., & Ito, F. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.008 · Cited by 36
The Extracellular NADome Modulates Immune Responses
Audrito, V., Messana, V. G., Brandimarte, L., & Deaglio, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704779 · Cited by 35
Rizzo, R., Ferrari, D., Melchiorri, L., Stignani, M., Gulinelli, S., Baricordi, O. R., & Virgilio, F. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804265 · Cited by 34
The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis
Chekeni, F. B., & Ravichandran, K. S. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0673-7 · Cited by 34
Sim, S., Niwa, T., Taguchi, H., & Aida, T. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b07925 · Cited by 33
Brisson, L., Chadet, S., Lopez‐Charcas, O., Jelassi, B., Ternant, D., Chamouton, J., Lerondel, S., Pape, A. L., Couillin, I., Gombault, A., et al. (2020) · Cancers · doi:10.3390/cancers12092342 · Cited by 35
Extracellular adenosine 5′-triphosphate in pulmonary disorders
Pelleg, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114319 · Cited by 33
Alternatively Spliced Isoforms of the P2X7 Receptor: Structure, Function and Disease Associations
Salis, S. K. F. D., Li, L., Chen, Z., Lam, K. W., Skarratt, K. K., Balle, T., & Fuller, S. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158174 · Cited by 33
Furuta, K., Onishi, H., Ikada, Y., Masaki, K., Tanaka, S., & Kaito, C. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104587 · Cited by 33
Yalak, G., & Olsen, B. R. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0482-4 · Cited by 32
Detection of Extracellular ATP in the Tumor Microenvironment, Using the pmeLUC Biosensor
Marchi, E. D., Orioli, E., Pegoraro, A., Adinolfi, E., & Virgilio, F. D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9717-6_13 · Cited by 32
Vinette, V., Placet, M., Arguin, G., & Gendron, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136080 · Cited by 32
Hypothermic microenvironment plays a key role in tumor immune subversion
Du, G., Liu, Y., Li, J., Liu, W., Wang, Y., & Li, H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.018 · Cited by 32
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 31
Corrado, M., Scorrano, L., & Campello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8727 · Cited by 31
A Purinergic Trail for Metastases
Ferrari, D., Malavasi, F., & Antonioli, L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.010 · Cited by 31
Hope, J. M., Greenlee, J. D., & King, M. R. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000312 · Cited by 32
Immunomodulatory effects of P2X7 receptor in intracellular parasite infections
Savio, L. E. B., & Coutinho‐Silva, R. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.005 · Cited by 31
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
Tattersall, L., Shah, K. M., Lath, D., Singh, A., Down, J. M., Marchi, E. D., Williamson, A., Virgilio, F. D., Heymann, D., Adinolfi, E., et al. (2021) · Journal of bone oncology · doi:10.1016/j.jbo.2021.100398 · Cited by 31
Engineering Aptamers with Selectively Enhanced Biostability in the Tumor Microenvironment
Xie, S., Wang, Z., Fu, T., Zheng, L., Wu, H., He, L., Huang, H., Cai, Y., Wang, R., Qian, X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202201220 · Cited by 31
Cao, Y., Chen, E., Wang, X., Song, J., Zhang, H., & Chen, X. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02859-0 · Cited by 31
Burm, S. M., Zuiderwijk-Sick, E. A., Weert, P. M., & Bajramovic, J. J. (2016) · Glia · doi:10.1002/glia.23059 · Cited by 31
Pinto, A., & Pocard, M. D. (2019) · Pleura and Peritoneum · doi:10.1515/pp-2019-0006 · Cited by 30
Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Tewari, M., Michalski, S. A., & Egan, T. M. (2024) · Cells · doi:10.3390/cells13020161 · Cited by 36
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy
Kalhan, A., Gharibi, B., Vazquez, M., Jasani, B., Neal, J., Kidd, M. S., Modlin, I. M., Pfragner, R., Rees, A., & Ham, J. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9280-5 · Cited by 29
Roles of purinergic P2X 7 receptor in glioma and microglia in brain tumors
McLarnon, J. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.004 · Cited by 30
TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy
Sudi, S. B., Tanaka, T., Oda, S., Nishiyama, K., Nishimura, A., Sunggip, C., Mangmool, S., Numaga‐Tomita, T., & Nishida, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46252-2 · Cited by 30
Biological insights from the direct measurement of purine release.
Dale, N. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114416 · Cited by 23
Purinergic signaling in nervous system health and disease: Focus on pannexin 1
Sanchez‐Arias, J. C., van der Slagt, E., Vecchiarelli, H. A., Candlish, R. C., York, N. S., Young, P. A., Shevtsova, O., Juma, A., Tremblay, M., & Swayne, L. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107840 · Cited by 28
P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy
Wanhainen, K. M., Peng, C., Zhou, M. H., Macedo, B. D. G., O’Flanagan, S. D., Yang, T., Kelekar, A., Burbach, B. J., da Silva, H. B., & Jameson, S. C. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0691 · Cited by 29
The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
Kvist, T., Schwarz, P., & Jørgensen, N. R. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/954530 · Cited by 29
Moinuddin, A., Poznanski, S. M., Portillo, A. L., Monteiro, J. K., & Ashkar, A. A. (2024) · Immunological Reviews · doi:10.1111/imr.13316 · Cited by 29
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction
Khalafalla, M. G., Woods, L. T., Jasmer, K. J., Forti, K. M., Camden, J. M., Jensen, J. L., Limesand, K. H., Galtung, H. K., & Weisman, G. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00222 · Cited by 28
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Lin, H.-J. L., Liu, Y., Lofland, D., & Lin, J. (2022) · Cancers · doi:10.3390/cancers14020285 · Cited by 28
Su, Y., Chen, X., Wang, H., Sun, L., Xu, Y., & Li, D. (2022) · Chemical Science · doi:10.1039/d2sc00371f · Cited by 28
Ring, S., Enk, A., & Mahnke, K. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.50 · Cited by 28
Li, Z., Acharya, R., Wang, S., & Schanze, K. S. (2018) · Journal of Materials Chemistry C · doi:10.1039/c7tc05081j · Cited by 28
Purinergic Calcium Signals in Tumor-Derived Endothelium
Scarpellino, G., Genova, T., Avanzato, D., Bernardini, M., Bianco, S., Petrillo, S., Tolosano, E., Vieira, J. R. D. A., Bussolati, B., Fiorio, A., et al. (2019) · Cancers · doi:10.3390/cancers11060766 · Cited by 28
Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists
Idrissi, I. G. E., Podlewska, S., Abate, C., Bojarski, A. J., Lacivita, E., & Leopoldo, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230403094538 · Cited by 28
Aptamer–Target Binding Triggered Molecular Mediation of Singlet Oxygen Generation
Tang, Z., Zhu, Z., Mallikaratchy, P. R., Yang, R., Sefah, K., & Tan, W. (2010) · Chemistry - An Asian Journal · doi:10.1002/asia.200900545 · Cited by 27
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question
Hreich, S. J. D., Benzaquen, J., Hofman, P. M., & Vouret‐Craviari, V. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09811-9 · Cited by 27
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis
Meng, X., Wang, L., Zhao, D., Zhao, D., Shen, Y., Yao, Y., Jing, W., Man, S., Dai, Y., & Zhao, Y. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.016 · Cited by 27
Morelli, A. M., & Scholkmann, F. (2024) · Biochimie · doi:10.1016/j.biochi.2024.01.018 · Cited by 32
Curet, M., & Watters, J. J. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2700-9 · Cited by 27
Sunna, S. N., Bowen, C. A., Zeng, H., Rayaprolu, S., Kumar, P., Bagchi, P., Dammer, E. B., Guo, Q., Duong, D. M., Bitarafan, S., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100546 · Cited by 27
Untangling Macropore Formation and Current Facilitation in P2X7
Cevoli, F., Arnould, B., Peralta, F. A., & Grütter, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310896 · Cited by 26
Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment
Laubach, K., Turan, T., Mathew, R. S., Wilsbacher, J. L., Engelhardt, J., & Samayoa, J. A. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.60 · Cited by 27
The Hyposensitive N187D P2X7 Mutant Promotes Malignant Progression in Nude Mice
Chong, J.-H., Zheng, G., Ma, Y., Zhang, H., Nie, K., Lin, Y., & Wu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128488 · Cited by 26
In Memoriam Geoffrey Burnstock: Creator of Purinergic Signaling
Verkhratsky, A., Zimmermann, H., Abbracchio, M. P., Illés, P., & Virgilio, F. D. (2020) · Function · doi:10.1093/function/zqaa006 · Cited by 26
Purinergic receptors and the inflammatory response mediated by lipids
Alarcón‐Vila, C., Pizzuto, M., & Pelegrı́n, P. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.004 · Cited by 25
Dillard, C., Borde, C., Mohammad, A., Puchois, V., Jourdren, L., Larsen, A. K., Sabbah, M., Maréchal, V., Escargueil, A. E., & Pramil, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111472 · Cited by 26
Yoshida, O., Dou, L., Kimura, S., Yokota, S., Isse, K., Robson, S. C., Geller, D. A., & Thomson, A. W. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.01.003 · Cited by 26
Paustian, C. C., Taylor, P., Johnson, T. D., Xu, M., Ramirez, N., Rosenthal, K. S., Shu, S., Cohen, P. A., Czerniecki, B. J., & Koski, G. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054804 · Cited by 26
GL261 glioma tumor cells respond to ATP with an intracellular calcium rise and glutamate release
Strong, A. D., Indart, M. C., Hill, N. R., & Daniels, R. L. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3272-5 · Cited by 29
Bertoni, A. P. S., Bracco, P. A., de Campos, R. P., Lutz, B. S., Brasil, B. A., Meyer, E. L. D. S., Saffi, J., Braganhol, E., Furlanetto, T. W., & Wink, M. R. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.013 · Cited by 25
Khalid, M., Manzoor, S., Ahmad, H., Asif, A., Bangash, T. A., Latif, A., & Jaleel, S. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4432-0 · Cited by 25
Manfredini, M., Giuliani, A. L., Ruina, G., Gafà, R., Bosi, C., Zoppas, E., Virgilio, F. D., & Bettoli, V. (2019) · Dermatology · doi:10.1159/000502026 · Cited by 25
The Multifaceted Role of P2X7R in Microglia and Astrocytes
Bedetta, M., Pizzo, P., & Lia, A. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04502-y · Cited by 28
Huang, R., Li, G., Wang, Z., Hu, H., Zeng, F., Zhang, K., Wang, K., & Wu, F. (2020) · Cancer Science · doi:10.1111/cas.14484 · Cited by 24
Bai, X., Li, Q., Peng, X., Li, X., Qiao, C., Tang, Y., & Zhao, R. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09928-z · Cited by 25
Becerra, S. P. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1431 · Cited by 24
Extracellular nucleotide regulation and signaling in cardiac fibrosis
Novitskaya, T., Chepurko, E., Covarrubias, R., Novitskiy, S. V., Ryzhov, S. V., Feoktistov, I., & Gumina, R. J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.010 · Cited by 24
The roles of unfolded protein response pathways in Chlamydia pathogenesis
George, Z., Omosun, Y., Azenabor, A. A., Partin, J. V., Joseph, K., Ellerson, D., He, Q., Eko, F. O., BANDEA, C. I., Svoboda, P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw569 · Cited by 24
Hosseinkhani, S., Amandadi, M., Ghanavatian, P., Zarein, F., Ataei, F., Nikkhah, M., & Vandenabeele, P. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00743j · Cited by 25
Impaired P2X1 Receptor–Mediated Adhesion in Eosinophils from Asthmatic Patients
Wright, A. K. A., Mahaut‐Smith, M. P., Symon, F. A., Sylvius, N. B., Ran, S., Bafadhel, M., Muessel, M. J., Bradding, P. H., Wardlaw, A. J., & Vial, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501585 · Cited by 23
Double‐Lock Nanomedicines Enable Tumor‐Microenvironment‐Responsive Selective Antitumor Therapy
Liu, F., Zhu, J., Dai, P., Deng, J., Qin, J., Yuchi, Z., Fan, A., Wang, Z., & Zhao, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009157 · Cited by 23
Yoshinaga, N., Uchida, S., Dirisala, A., Naito, M., Koji, K., Osada, K., Cabral, H., & Kataoka, K. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102016 · Cited by 23
P2X7 receptor activation impairs antitumour activity of natural killer cells
Baroja‐Mazo, A., Peñín‐Franch, A., Lucas‐Ruiz, F., de Torre‐Minguela, C., Alarcón‐Vila, C., Hernández‐Caselles, T., & Pelegrı́n, P. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15951 · Cited by 22
P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization
Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H. K., & Yang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03985-z · Cited by 24
Block, G. J., DiMattia, G. E., & Prockop, D. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010237 · Cited by 23
Zhao, R., Liang, D., & Sun, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155953 · Cited by 23
Cellular Migration Ability Is Modulated by Extracellular Purines in Ovarian Carcinoma SKOV‐3 Cells
Martínez-Ramírez, A. S., Díaz‐Muñoz, M., Battastini, A. M. O., Campos‐Contreras, A. D. R., Olvera, A., Bergamin, L. S., Glaser, T., Moritz, C. E. J., Ulrich, H., & Vázquez‐Cuevas, F. G. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26104 · Cited by 23
Overview of the role of purinergic signaling and insights into its role in cancer therapy
Virgilio, F. D., Vultaggio-Poma, V., Tarantini, M., & Giuliani, A. L. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108700 · Cited by 25
Huang, T., Ren, X., Tang, X., Wang, Y., Ji, R., Guo, Q., Ma, Q., Zheng, Y., Hu, Z., & Zhou, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427380 · Cited by 28
The Trend of Nonenzymatic Nucleic Acid Amplification: Strategies and Diagnostic Application
Li, J., Li, T., Zou, Z., & Li, H. (2025) · Precision Chemistry · doi:10.1021/prechem.4c00100 · Cited by 22
The signaling effects of ATP on melanoma-like skin cancer
Mânica, A., Bonadiman, B. D. S. R., Cardoso, A. M., Paiz, A., Siepko, C. M., de Souza, J. V. G., Moreno, M., Moreno, A. V., Schetinger, M. R. C., Morsch, V. M., et al. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.03.021 · Cited by 22
Boedtkjer, E. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_63 · Cited by 22
Yang, J., Qu, J., Teng, X., Zhu, W. P., Xu, Y. F., Yang, Y. Y., & Qian, X. H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301084 · Cited by 23
Kurashima, Y., Kiyono, H., & Kunisawa, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/427125 · Cited by 23
Zhang, C., Wei, Z., & Ye, B. (2013) · Biotechnology Journal · doi:10.1002/biot.201300001 · Cited by 25
Ectokinases as novel cancer markers and drug targets in cancer therapy
Yalak, G., & Viola Vogel, B. (2014) · Cancer Medicine · doi:10.1002/cam4.368 · Cited by 21
Nie, J., Huang, G., Deng, S., Bao, Y., Liu, Y., Feng, Z., Wang, C., Chen, M., Qi, S., & Pan, J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0338 · Cited by 22
Induction of antiinflammatory purinergic signaling in activated human iNKT cells
Yu, J. C., Lin, G., Field, J. J., & Linden, J. M. (2018) · JCI Insight · doi:10.1172/jci.insight.91954 · Cited by 22
A Self‐Assembled ATP Probe for Melanoma Cell Imaging
Cheng, H., Sun, Z., Kwon, N., Wang, R., Cui, Y., Park, C. O., & Yoon, J. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201806182 · Cited by 22
Bobba, K. N., Binoy, A., Koo, S., Nedungadi, D., Podder, A., Sharma, A. K., Mishra, N., Kim, J. S., & Bhuniya, S. (2019) · Chemical Communications · doi:10.1039/c9cc01483g · Cited by 22
McClenahan, D. J., Hillenbrand, K., Kapur, A., Carlton, D. P., & Czuprynski, C. J. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00282-08 · Cited by 22
Adinolfi, E., Marchi, E. D., Grignolo, M., Szymczak, B., & Pegoraro, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813906 · Cited by 22
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states
Li, K., Girardi, E., Kartnig, F., Grosche, S., Pemovska, T., Bigenzahn, J. W., Goldmann, U., Sedlyarov, V., Bensimon, A., Schick, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00386-8 · Cited by 21
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
Lim, H., Oh, C., Park, M., Park, H.-B., Ahn, C., Bae, W. K., Yoo, K. H., & Hong, S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04414 · Cited by 21
Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening
Sachsenmeier, K. F., Hay, C. M., Brand, E., Clarke, L., Rosenthal, K., Guillard, S., Rust, S. J., Minter, R., & Hollingsworth, R. E. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112443987 · Cited by 21
Nanoparticle‐Based Activatable Probes for Bioimaging
Ma, T., & Xia, T. (2021) · Advanced Biology · doi:10.1002/adbi.202000193 · Cited by 20
Foster, J. G., Carter, E. P., Kilty, I., Mackenzie, A. B., & Ward, S. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201510 · Cited by 23
Metadata
- Authors
- Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F.
- Affiliations
- University of Ferrara (IT)
- Istituto Giannina Gaslini (IT)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-07-09
- Volume
- 3
- Issue
- 7
- Pages
- e2599
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2440522
- OpenAlex
- W2070663123
- Cited by
- 668
- References
- 28
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 29 · 2023: 62 · 2022: 51 · 2021: 58 · 2020: 66 · 2019: 42 · 2018: 37 · 2017: 34 · 2016: 33 · 2015: 25 · 2014: 36 · 2013: 28 · 2012: 40
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- Fondazione Italiana per la Lotta al Neuroblastoma
- Associazione Italiana per la Ricerca sul Cancro (GGP06070)
- Università degli Studi di Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
- Keywords
- extracellular ATP, tumor microenvironment, in vivo imaging, adenosine, adenosine A2A receptor, immunosuppression, ATP catabolism, adenosine transporter
- MeSH terms
- Adenosine Triphosphate, Animals, Cell Membrane, Extracellular Space, Humans, Luciferases, Luminescent Measurements, Mice, Nude, Neoplasms, Cell Line, Tumor, Luminescent Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review